BridgeMD
A PHASE III OPEN LABEL STUDY CONTROLLED BY VITAMIN D3 SUPPLEMENTATION AND THE DIFFERENCES BETWEEN YOUNG ADULTS AND SENIOR POPULATION
EU CTIS ID: 2024-511889-36-01
What this study is testing
The main objective of this study is to compare the efficacy of vitamin D3 supplementation in the young and elderly population with the same dosing schedule and to develop an effective supplementation model for each age group based on the differences found.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. I ndividuals who agreed to participate without any excluding conditions 2. Age 20 27 or 65 85 years 3. Women of childbearing potential ( must use highly effective contraception for the duration of the study 4. BMI 18,5 and <30 5. White race
You likely can't join if
- 1. Recent vitamin D supplementation (in the past two months and during the study) 2. Hypercalcemia 3. Renal osteodystrophy with hypercalcemia 4. Current therapy with thiazide diuretic s 5. Current therapy with corticosteroids 6. Women who are pregnant, breastfeeding and planning a pregnancy at the time of the study 7. Endocrine disease or any medical condition with presumed autoimmune background (rheumatoid diseases, etc) 8. Vitamin D levels 200 nmol/L 9 Malabsorption syndromes 10 Any type or staging of malignancy 11 Any condition limiting the life expectancy to less than 12 months 12 Calcium levels over 2,75 mmol/l 1 3 Phosphate levels over 1,5 mmol/l 14. A llergy to cholecalciferol or any other component of Vigantol
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.